Ralf Gold
University Hospitals of the Ruhr-University of Bochum
Affiliation University Hospitals of the Ruhr-University of Bochum Top Publications Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis (2012) – 1,741 citations Spatial and temporal heterogeneity of mouse and human microglia at single-cell resolution (2019) – 1,407 citations Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant ... <a title="Ralf Gold" class="read-more" href="https://journalsworld.com/researchers/ralf-gold/" aria-label="Read more about Ralf Gold">Read more</a>
Read biography ↓Biography, research & contributions
Affiliation
University Hospitals of the Ruhr-University of Bochum
Top Publications
- Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis (2012) - 1,741 citations
- Spatial and temporal heterogeneity of mouse and human microglia at single-cell resolution (2019) - 1,407 citations
- Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway (2011) - 1,197 citations
- Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study (2018) - 949 citations
- Dietary Fatty Acids Directly Impact Central Nervous System Autoimmunity via the Small Intestine (2015) - 945 citations
At a glance
- Full name
- Ralf Gold
- ORCID
- 0000-0002-7223-3052
- OpenAlex ID
- https://openalex.org/A5062220148
Research interests
- Multiple Sclerosis Research Studies, Peripheral Neuropathies and Disorders, Psoriasis: Treatment and Pathogenesis, Polyomavirus and related diseases, T-cell and B-cell Immunology
Research topics
Education
Not yet documented in this profile.
Selected research & further reading
A curated reading list, not a ranking by citation count. References use DOI metadata, matching public scholarly records or authoritative lecture sources.
See the source-linked reading and original works in the research guide above.
Citation & publication trends
Annual counts are not yet available from a verified author record. Explore the research guide above for the work itself; publication and citation totals depend on database coverage.
Source: OpenAlex · Retrieved 2026-10-08. Metrics are database-specific and are not a scientific ranking.
Most-cited linked publications
Publications matched across ORCID and OpenAlex. Citation counts are source-specific.
- Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis ↗2012 · New England Journal of Medicine1,741OpenAlex citations
- 1,407OpenAlex citations
- 1,197OpenAlex citations
- 949OpenAlex citations
- 945OpenAlex citations
Recent linked publications
Publications matched across ORCID and OpenAlex. Citation counts are source-specific.
- Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis ↗2012 · New England Journal of Medicine
Journals published in
No verified record links added yet.
Related publishers
No verified record links added yet.
Institutions
Current verified institution
No verified record links added yet.
Previous institutions
No verified record links added yet.
Awards & honors
Not yet documented in this profile.
Career timeline
Not yet documented in this profile.
Co-authors
No verified record links added yet.
Education & career institution links
No verified record links added yet.
Claim & manage this profile
Are you this researcher? Sign in, provide identity evidence, and request administrator approval. Editing becomes available only after approval.
Sign in to claim this profileSources & data information
Editorial review: 2026-10-08 · Last data update: 2026-10-08 00:34:09
Unknown values are left blank. Linked publications may be a subset of total works. Identity verification, data retrieval and profile ownership are separate checks.